Kerber USA Inc

Form 483 issued November 2, 2022 · Amherst, New York

Inspection
Oct 31 – Nov 2, 2022
Observations
7
Pages
5
FEI number
3017419219

In short: On November 2, 2022, FDA issued a Form 483 with 7 observations to Kerber USA Inc in Amherst, New York (FEI 3017419219) after an inspection that ran Oct 31 – Nov 2, 2022. The investigator was Matthew D. Schnittker. Most observations concern cAPA and design controls.

At a glance

Observations span 4 systems, led by capa.

CAPA3
Design controls1
Management controls1
Records & documents1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for design control…

  2. 02

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit…

  3. 03

    Procedures for corrective and preventive action…

  4. 04

    Procedures for quality audits…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Kerber USA Inc?

FDA listed 7 observations on this Form 483, mostly about cAPA, design controls and management controls. The opening words of each observation are shown on this page.

Who inspected Kerber USA Inc?

Matthew D. Schnittker is named on this Form 483, for the inspection of Oct 31 – Nov 2, 2022. Each investigator has a profile showing what they cite most.

When was Kerber USA Inc inspected by FDA?

The inspection ran Oct 31 – Nov 2, 2022, and the Form 483 is dated November 2, 2022.

How do I get the full Form 483 for Kerber USA Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free